HeartBeam Corporation - צמיחת רווחי EPS רבעונית BEAT
HeartBeam, Inc. (BEAT) is shielded by domestic US demand but remains dependent on global chip supplies. The company is building a remote cardiology network through cloud integration of 3D-ECG. As the project currently awaits FDA approval, the stock valuation remains venture-like. The quarterly percentage growth in earnings per share reflects the business dynamics, where the indicator value stands at 35.50.
%20%D7%A6%D7%9E%D7%99%D7%97%D7%AA%20%D7%A8%D7%95%D7%95%D7%97%20%D7%9C%D7%9E%D7%A0%D7%99%D7%94%20%D7%9E%D7%A9%D7%A0%D7%94%20%D7%9C%D7%A9%D7%A0%D7%94%20%D7%91%D7%A9%D7%A0%D7%99%D7%9D%20%D7%A2%D7%A9%D7%A8%20%D7%94%D7%97%D7%95%D7%93%D7%A9%D7%99%D7%9D%20%D7%94%D7%90%D7%97%D7%A8%D7%95%D7%A0%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_BEAT_-_HeartBeam-Inc._-_Year-over-year-earnings-per-share-growth-for-the-last-twelve-months "HeartBeam Corp (BEAT) - צמיחת רווחי EPS רבעונית מ-04.07.2022 עד 13.11.2026 | 👁️GURU.Markets👁️")
פילוחים אנליטיים ודוחות נתונים של חברת HeartBeam Corporation (BEAT)
Earnings per share dynamics measure the pace of net income generation, reflecting real operational efficiency and the business's ability to scale margins. A stable quarterly EPS trend confirms the maturity of HeartBeam, Inc., whose resilience to macroeconomic shocks is ensured by constant demand for medical services, making this indicator a reliable filter for assessing long-term capital potential.
